For citations:
Stepanova V.N., Holownia-Voloskova M.E., Andreev D.A., Ermolaeva A.D., Davydovskaya М.V., Kokushkin K.A. TARGETED DRUG BRENTUXIMAB VEDOTIN FOR TREATMENT OF RELAPSED OR REFRACTORY CD30-POSITIVE HODGKIN’S LYMPHOMA. Malignant tumours. 2017;7(4):63-76. (In Russ.) https://doi.org/10.18027/2224-5057-2017-7-4-63-76
Email this article 